Miranda Novell

Miranda Novell is a journalist at The Eastern Herald covering sexual health, wellness, spirituality, travel, tourism and hospitality, with a focus on health, lifestyle and travel-related developments.

Illustration representing Alexander disease, a rare genetic neurological disorder caused by GFAP gene mutations affecting astrocytes in the brain

A Fatal Neurological Disease With No Treatment Just Got Its First Drug

The FDA's September 3 approval of Zanvastro marks the first disease-modifying treatment for Alexander disease, an ultra-rare neurological disorder affecting roughly one in one million people. The drug targets the genetic root

September 8, 2026

Rosalba Hernandez, researcher at the University of Illinois Urbana-Champaign, whose review of 18 clinical trials confirmed mindfulness lowers blood pressure

Scientists Confirmed That Mindfulness Lowers Blood Pressure. There’s a Catch.

A review of 18 clinical trials found that structured mindfulness programs lower blood pressure by up to 7.6 mmHg and reduce inflammatory markers within weeks. The physiological gains do not persist once programs end, a durability problem that cardiovascular medicine

September 6, 2026

Illustration representing neurological research into multiple sclerosis and brain health

The MS Pill That Beat Standard Therapy and Cleared the Safety Bar Its Rival Could Not

A Novartis oral pill for relapsing multiple sclerosis outperformed standard therapy in two large Phase III

Research from the University of Birmingham shows immune cells retain a molecular memory of obesity for up to a decade after weight loss

Your Body Remembers When It Was Obese. The Memory Can Last a Decade.

Your immune cells keep a molecular record of every year spent with obesity, and that record

A CPAP continuous positive airway pressure machine the standard treatment for obstructive sleep apnea before pill alternatives

Millions Refused the CPAP Mask. This Sleep Apnea Pill Just Entered FDA Review.

The FDA has accepted for review Oxnimbi (AD109), a once-nightly pill for sleep apnea patients who refused CPAP. In a Phase 3 trial of 646 patients, it cut breathing interruptions by 44

September 5, 2026

Health·News

WHO and DRC health workers respond to the 2026 Ebola outbreak in eastern Democratic Republic of the Congo

The Deadliest Ebola Outbreak on Record Is Spreading — The World Is Still Playing Catch-Up

The 2026 DRC Ebola outbreak has surpassed 6,000 confirmed cases and nearly 3,000 deaths, the largest in recorded history. The Bundibugyo strain has no licensed vaccine and no approved treatment, leaving MSF's

September 2, 2026

Health·News

Elderly woman looking out window, representing dementia risk research in adults over 90

Getting Past 90 Was Supposed to Be Enough. For Women and Black Adults, It Isn’t.

A landmark study in The Lancet Healthy Longevity tracked more than 800 adults past 90 and found that women face double the dementia risk of men, and Black adults carry a 75

September 1, 2026

Health·News

X-ray of knee joint affected by osteoarthritis showing varus deformity and joint space narrowing

A Single Joint Injection That Lasts Weeks Could Rewrite Osteoarthritis Treatment

University at Buffalo researchers have built an injectable hydrogel that stays in the joint for weeks, releasing Sirt6-targeted nanocarriers to fight cartilage aging. The platform could extend treatment well beyond the two-to-four-week

September 1, 2026

Health·News

GLP-1 receptor agonist oral pill aleniglipron diabetes obesity treatment clinical trial

They Fought Obesity With Injections for Years: This Daily Pill Just Changed the Math

An oral GLP-1 pill produced 12.1% body weight loss over 36 weeks without injections or fasting, Phase 2b data in Nature Medicine shows. Results push aleniglipron to the front rank of oral

September 1, 2026

Health·News

Air pollution PM2.5 fine particulate matter exposure linked to cognitive decline and brain health effects in older adults

HEPA Air Purifier for One Month Improved Brain Speed by 12% in Older Adults

A randomized trial found that running a HEPA air purifier at home for one month improved executive function by 12% in adults aged 40 and older who lived near busy highways —

September 1, 2026

Health·News

Stevia rebaudiana plant with small white flowers, the source of the natural sweetener tested in the Universidad de Chile multigenerational mouse study

Sweeteners Sucralose and Stevia Altered Gut and Genes in Mice Across Two Generations

A Frontiers in Nutrition study from Universidad de Chile found sucralose and stevia passed gut microbiome and gene expression changes to two generations of offspring who never consumed the sweeteners — raising

September 1, 2026

Health·News

Clinical photograph of severe periodontitis showing gum recession and bone loss around teeth in a patient with Stage III or IV gum disease

Omega-3 and Aspirin Matched Antibiotics for Severe Gum Disease in New Trial

A year-long randomized clinical trial found omega-3 fatty acids and low-dose aspirin matched antibiotics for severe gum disease — offering an antibiotic-sparing option in a field where overuse of antimicrobials is increasingly

September 1, 2026

Health·News

Colorized scanning electron micrograph of H1N1 influenza virus particles, the pathogen type mFlusiva is designed to protect against as the first mRNA flu vaccine approved by the FDA

FDA Approves mFlusiva, the First mRNA Flu Vaccine, Despite Push to Block It

The Food and Drug Administration approved mFlusiva on August 5, making Moderna's shot the first mRNA influenza vaccine cleared in the United States for adults 50 and older. The approval survived an

September 1, 2026

Health·News

Shingrix recombinant shingles vaccine box and Zostavax, the older vaccine, studied in connection with 24% lower dementia risk in older adults

Shingrix Linked to 24% Lower Dementia Risk in a Study of 500,000 Older Adults

A study of more than 509,000 older Americans found that Shingrix recipients were 24 percent less likely to develop dementia over four years than unvaccinated adults, raising new questions about whether the

September 1, 2026

Health·News

1 2 3 … 19 Next

Miranda Novell

A Fatal Neurological Disease With No Treatment Just Got Its First Drug

Scientists Confirmed That Mindfulness Lowers Blood Pressure. There’s a Catch.

The MS Pill That Beat Standard Therapy and Cleared the Safety Bar Its Rival Could Not

Your Body Remembers When It Was Obese. The Memory Can Last a Decade.

Millions Refused the CPAP Mask. This Sleep Apnea Pill Just Entered FDA Review.

The Deadliest Ebola Outbreak on Record Is Spreading — The World Is Still Playing Catch-Up

Getting Past 90 Was Supposed to Be Enough. For Women and Black Adults, It Isn’t.

A Single Joint Injection That Lasts Weeks Could Rewrite Osteoarthritis Treatment

They Fought Obesity With Injections for Years: This Daily Pill Just Changed the Math

HEPA Air Purifier for One Month Improved Brain Speed by 12% in Older Adults

Sweeteners Sucralose and Stevia Altered Gut and Genes in Mice Across Two Generations

Omega-3 and Aspirin Matched Antibiotics for Severe Gum Disease in New Trial

FDA Approves mFlusiva, the First mRNA Flu Vaccine, Despite Push to Block It

Shingrix Linked to 24% Lower Dementia Risk in a Study of 500,000 Older Adults

Radical Islam is being appreciated by Indian authorities too

Bangladesh; India’s Biggest Ally or China’s Dragon Nest?

Ahmadis in Bangladesh face fresh threat of persecution

Latest Posts

Diesel Hit a Record $6.53 a Gallon. Trump’s Answer Is to Stop Selling It Abroad.

Trump Claims Ukraine and Russia Agreed to Halt Energy Strikes, Kyiv Said It Was Not Informed

Iran Delivers Its Peace Conditions to US Envoys in a Three-Hour UN Meeting

Russia Strikes Dnipro Steel Plant as Zelenskyy Declares Energy Truce

Miranda Novell

Follow

Latest Posts